Molly Franke, PA
Physician Assistant · Ottumwa, IANPI 1306823281
Payments from drug & device makers
Across 139 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$561
- Sun Pharmaceutical Industries Inc.$549
- AbbVie$458
- E.r. Squibb & Sons, L.L.C.$354
- Novartis$312
- UCB, Inc.$256
- plus $591 from 13 others
What the payments were for
- Food & beverage$2,42479%
- Education$65621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $561 |
| Sun Pharmaceutical Industries Inc. | 20 | $549 |
| AbbVie | 24 | $458 |
| E.r. Squibb & Sons, L.L.C. | 22 | $354 |
| Novartis | 13 | $312 |
| UCB, Inc. | 11 | $256 |
| Pfizer | 7 | $126 |
| Lilly USA, LLC | 3 | $63 |
| Arcutis Biotherapeutics, Inc. | 3 | $61 |
| Galderma Laboratories, L.p. | 4 | $58 |
| Tactile Systems Technology Inc | 1 | $51 |
| Boehringer Ingelheim | 2 | $48 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
| Dermavant Sciences, Inc. | 2 | $28 |
| Amgen | 1 | $28 |
| Biofrontera Inc. | 2 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Convatec Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $13 |
How this compares
$3,080 in reported general payments places this provider in the 90th percentile of 1,140 physician assistant providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 46 | $180,781 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $88,418 |
| Tacrolimus | 25 | $2,932 |
| ValacyclovirValacyclovir Hcl | 23 | $2,148 |
| Clobetasol Propionate | 37 | $1,845 |
| Ketoconazole | 70 | $992 |
| Hydroxychloroquine Sulfate | 17 | $576 |
| Triamcinolone Acetonide | 68 | $567 |
| Clindamycin Phosphate | 12 | $554 |
| Doxycycline Monohydrate | 38 | $533 |
| Doxycycline Hyclate | 17 | $321 |
| Fluocinonide | 11 | $289 |
| Mometasone Furoate | 18 | $214 |
| Silver Sulfadiazine | 17 | $201 |
| Mupirocin | 25 | $193 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Ottumwa
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
- Michon LeddyClive$73K
- Kyle HawkinsIowa City$42K
- Andrew MetzgerIowa City$37K
- Myrl HolidaIowa City$37K
- Kelly MerchieDavenport$15K
- Kathleen DuffyClive$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.